Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1990 1
1991 1
1993 2
1994 2
1995 2
1996 3
1997 1
1999 3
2000 2
2003 2
2004 1
2005 2
2006 1
2008 3
2009 1
2010 3
2011 5
2012 3
2013 5
2014 5
2015 2
2016 1
2017 2
2018 7
2019 5
2020 14
2021 6
2022 4
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Inherited neuroendocrine tumor"
Page 1
Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis.
Rao L, Wu L, Liu Z, Tian R, Yu G, Zhou Z, Yang K, Xiong HG, Zhang A, Yu GT, Sun W, Xu H, Guo J, Li A, Chen H, Sun ZJ, Fu YX, Chen X. Rao L, et al. Nat Commun. 2020 Sep 30;11(1):4909. doi: 10.1038/s41467-020-18626-y. Nat Commun. 2020. PMID: 32999291 Free PMC article.
Also, cancer cells secrete stimulating factors, which polarize tumor-associated macrophages from an antitumor M1 phenotype to a tumorigenic M2 phenotype. ...These properties, combined with the capabilities inherited from source cells, make hNVs an attractive immunot …
Also, cancer cells secrete stimulating factors, which polarize tumor-associated macrophages from an antitumor M1 phenotype to a tumor …
Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies.
Ruggeri RM, Benevento E, De Cicco F, Fazzalari B, Guadagno E, Hasballa I, Tarsitano MG, Isidori AM, Colao A, Faggiano A; NIKE Group. Ruggeri RM, et al. J Endocrinol Invest. 2023 Feb;46(2):213-234. doi: 10.1007/s40618-022-01905-4. Epub 2022 Aug 30. J Endocrinol Invest. 2023. PMID: 36038743 Review.
PURPOSE: Neuroendocrine neoplasms can occur as part of inherited disorders, usually in the form of well-differentiated, slow-growing tumors (NET). ...In the present review, we propose a reappraisal of the genetic basis and clinical features of gastroen …
PURPOSE: Neuroendocrine neoplasms can occur as part of inherited disorders, usually in the form of well-differentiated, slow-g …
Pancreatic endocrine tumors.
Oberg K. Oberg K. Semin Oncol. 2010 Dec;37(6):594-618. doi: 10.1053/j.seminoncol.2010.10.014. Semin Oncol. 2010. PMID: 21167379 Review.
They represent a heterogeneous group with very varying tumor biology and prognosis. About half of the patients present clinical symptoms and syndromes related to substances released from the tumors (Zollinger-Ellison syndrome, insulinoma, glucagonoma, etc) an …
They represent a heterogeneous group with very varying tumor biology and prognosis. About half of the patients present clinical …
Molecular profiling of pancreatic neuroendocrine tumors (pNETS) and the clinical potential.
Camilli M, Papadimitriou K, Nogueira A, Incorvaia L, Galvano A, D'Antonio F, Ferri J, Santini D, Silvestris N, Russo A, Peeters M, Rolfo C. Camilli M, et al. Expert Rev Gastroenterol Hepatol. 2018 May;12(5):471-478. doi: 10.1080/17474124.2018.1463157. Epub 2018 Apr 18. Expert Rev Gastroenterol Hepatol. 2018. PMID: 29629846 Review.
Pancreatic neuroendocrine tumors (pNETs) represent a small part of pancreatic neoplasms, and the knowledge about their indolent clinical course remains a subject of investigation. ...The review also discusses functional and non-functional pNETs and associated …
Pancreatic neuroendocrine tumors (pNETs) represent a small part of pancreatic neoplasms, and the knowledge about their indolen …
Medullary Thyroid Carcinoma in Children.
Graves CE, Gosnell JE. Graves CE, et al. Semin Pediatr Surg. 2020 Jun;29(3):150921. doi: 10.1016/j.sempedsurg.2020.150921. Epub 2020 May 16. Semin Pediatr Surg. 2020. PMID: 32571506 Review.
The vast majority of medullary thyroid carcinomas (MTC) in children are inherited as part of the multiple endocrine neoplasia (MEN) syndromes MEN2A and MEN2B, and the related variant, familial MTC. ...
The vast majority of medullary thyroid carcinomas (MTC) in children are inherited as part of the multiple endocrine neoplasia (MEN) s …
Update on Targeted Therapy in Medullary Thyroid Cancer.
Okafor C, Hogan J, Raygada M, Thomas BJ, Akshintala S, Glod JW, Del Rivero J. Okafor C, et al. Front Endocrinol (Lausanne). 2021 Aug 19;12:708949. doi: 10.3389/fendo.2021.708949. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34489865 Free PMC article. Review.
Medullary thyroid carcinoma (MTC) is a rare neuroendocrine tumor that accounts for 2-4% of all thyroid cancers. All inherited MTC and approximately 50% of sporadic cases are driven by mutations in the REarranged during Transfection (RET) proto-oncogene. ...
Medullary thyroid carcinoma (MTC) is a rare neuroendocrine tumor that accounts for 2-4% of all thyroid cancers. All inherit …
The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/Paraganglioma.
Peng S, Zhang J, Tan X, Huang Y, Xu J, Silk N, Zhang D, Liu Q, Jiang J. Peng S, et al. Front Endocrinol (Lausanne). 2020 Nov 24;11:586857. doi: 10.3389/fendo.2020.586857. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 33329393 Free PMC article. Review.
Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumors originating from chromaffin cells in the adrenal medulla (PCCs) or extra-adrenal sympathetic or parasympathetic paraganglia (PGLs). About 40% of PPGLs result from germline mutations and ther …
Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumors originating from chromaffin cells in the adrenal m …
Management of medullary thyroid cancer.
Ball DW. Ball DW. Minerva Endocrinol. 2011 Mar;36(1):87-98. Minerva Endocrinol. 2011. PMID: 21460789 Review.
Molecular genetics analyses have indicated that approximately 55% of medullary thyroid cancer (MTC) tumors bear activating mutations of the RET gene, including inherited and sporadic cases. ...RET is the most important target for recent systemic therapy trials of MT …
Molecular genetics analyses have indicated that approximately 55% of medullary thyroid cancer (MTC) tumors bear activating mutations …
Ophthalmic genetics/inherited eye disease.
Young TL. Young TL. Curr Opin Ophthalmol. 2003 Oct;14(5):296-303. doi: 10.1097/00055735-200310000-00011. Curr Opin Ophthalmol. 2003. PMID: 14502058 Review.
RECENT FINDINGS: Most genetic ocular disorders are not yet treatable and/or are without curative therapies because of our limited understanding of pathogenesis, and the need for well-designed and fully implemented animal model or human clinical trial testing of ther …
RECENT FINDINGS: Most genetic ocular disorders are not yet treatable and/or are without curative therapies because of our limited understand …
Germline genetic variability in pancreatic cancer risk and prognosis.
Gentiluomo M, Canzian F, Nicolini A, Gemignani F, Landi S, Campa D. Gentiluomo M, et al. Semin Cancer Biol. 2022 Feb;79:105-131. doi: 10.1016/j.semcancer.2020.08.003. Epub 2020 Aug 18. Semin Cancer Biol. 2022. PMID: 32818625 Review.
At the other end of the spectrum of inherited PC risk factors, rare high-penetrance variants co-segregating with the disease have been observed in familial cancer syndromes that include PC, or in families with multiple recurrence of PC alone. ...The role of common variants …
At the other end of the spectrum of inherited PC risk factors, rare high-penetrance variants co-segregating with the disease have bee …
83 results